Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Eric Bloodaxe and the Etiology of Paget’s Disease

David S. Pisetsky, MD, PhD  |  Issue: October 2009  |  October 1, 2009

My favorite part of the Jorvik Centre was the discussion of a Viking named Egril, son of Skalla-Grim. From skeletal remains, forensic experts established that Egril suffered from Paget’s disease, with a head made massive with Pagetic bone. This condition explained not only his grotesque and menacing appearance but also his legendary resistance to sword blows and other unkind attacks. The exhibit also noted that Egril had cold feet, lethargy, and headache. Did he have another condition that is all too common today?

Along with the picture of Egril’s distorted cranium was a disquisition on diseases transmitted from the Vikings. These diseases include Dupuytren’s contracture, which is called by some the Viking disease (Did you know that? I certainly didn’t); heart disease; multiple sclerosis; and Paget’s disease, which is also rampant in Iceland, another Viking hangout.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

One of the most fascinating but mystifying aspects of modern genetics concerns the reason for the perpetuation of genes for bad disease. Why should the chromosomes harbor DNA sequences that do mischief, such as stirring up arthritis or lupus? The usual explanation is that the gene in another context provides a selective advantage, with its protein product fighting malaria or the bubonic plague, for example. While the exhibit did not make the point explicitly, I could not help but wonder whether genes that strengthen the bones against swords, maces, and lances could have also caused Paget’s disease to flourish. When your enemy’s name is Eric Bloodaxe, your caput needs all the density it can get.

Gene–environment interactions are tricky to decipher, but when people lived by the sword and died by the sword, an occasional case of Paget’s disease may been a small price to pay for a gene that makes the bones veritable armor. Did the brutal and unrelenting wars of the past put selective pressure on other genes? Maybe genes that promote blood clotting were a lifesaver for a soldier skewered on the battlefield. Scientists and religionists may both not like the idea, but I think that man is part of the environment that is making our genes evolve.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Enough musing and thoughts of the past. In a future column, I will describe what else I learned in York, this time about arthritis in modern England.

Dr. Pisetsky is physician editor of The Rheumatologist and professor of medicine and immunology at Duke University Medical Center in Durham, N.C.

Page: 1 2 3 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:HealthcareHistoryNational Health Service (NHS)Paget’s diseaseTravel

Related Articles
    Set Realistic Career Goals to Reach Your Professional Potential

    Set Realistic Career Goals to Reach Your Professional Potential

    January 19, 2016

    As a rheumatologist, you’re used to having goals. After all, you set your sights on becoming a physician, achieved the necessary educational degrees and passed required exams. After meeting your educational goals, you landed a job at an academic medical center or an established rheumatology practice, or you may have started your own practice. So…

    The ACR’s State-of-the-Art Clinical Symposium: Rheumatologists Weigh in on Tough-to-Treat Cases, Paget’s Disease, Imaging

    July 14, 2015

    CHICAGO—A 49-year-old woman has had RA for eight years. She has a rheumatoid factor reading of 35, an aCCP reading of 160, erythrocyte sedimentation rate of 42, plus erosions. She has been on methotrexate. She tried etanercept for six months, but then it stopped working. She was on 40 mg of adalimumab weekly, but it…

    Rheum’s Role in the New National Health Service

    April 1, 2007

    What the United States can learn from the U.K. system

    The Canes of York

    November 1, 2009

    What can a walking stick tell us about U.S. healthcare?

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences